Publication:
Serum gamma-glutamyl transferase levels and in-hospital mortality in patients with acute heart failure

Simple item page
dc.contributor.authorTurfan, Murat
dc.contributor.authorTasal, Abdurrahman
dc.contributor.authorErdogan, Ercan
dc.contributor.authorVatankulu, Mehmet Akif
dc.contributor.authorJafarov, Parviz
dc.contributor.authorSonmez, Osman
dc.contributor.authorErtas, Gokhan
dc.contributor.authorBACAKSIZ, AHMET
dc.contributor.authorErgelen, Mehmet
dc.contributor.authorGoktekin, Omer
dc.contributor.institutionauthorBACAKSIZ, AHMET
dc.date.accessioned2020-10-22T21:35:43Z
dc.date.available2020-10-22T21:35:43Z
dc.date.issued2014-01-01T00:00:00Z
dc.description.abstractBackground: Acute heart failure (AHF) is a major cause of hospitalisation, morbidity and mortality worldwide. Gamma-glutamyl transferase (GGT) is an enzyme responsible for the extracellular catabolism of antioxidant glutathione and a potential risk indicator of cardiac mortality. Limited data exists on the prognostic value of circulating levels of GGT in patients hospitalised due to AHF.
dc.identifier.citationTurfan M., Tasal A., Erdogan E., Vatankulu M. A. , Jafarov P., Sonmez O., Ertas G., BACAKSIZ A., Ergelen M., Goktekin O., -Serum gamma-glutamyl transferase levels and in-hospital mortality in patients with acute heart failure-, KARDIOLOGIA POLSKA, cilt.72, ss.735-739, 2014
dc.identifier.doi10.5603/kp.a2014.0048
dc.identifier.pubmed24526562
dc.identifier.scopus84906861242
dc.identifier.urihttp://hdl.handle.net/20.500.12645/24852
dc.identifier.wosWOS:000341247300008
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleSerum gamma-glutamyl transferase levels and in-hospital mortality in patients with acute heart failure
dc.typeArticle
dspace.entity.typePublication
local.avesis.idef046675-76ad-4ff0-ad46-dce8f0192ed8
local.publication.isinternational1
relation.isAuthorOfPublicationaf75b431-3b28-42b6-93a9-357a5d965904
relation.isAuthorOfPublication.latestForDiscoveryaf75b431-3b28-42b6-93a9-357a5d965904
Files
Collections
Yayınlar - Eserler